阅读说明：本技术 指示ntrk致癌融合的候选标志的鉴定 (Identification of candidate markers indicative of NTRK oncogenic fusion ) 是由 A·施米茨 E·M·埃尔西德 F·斯塔夫罗波勒 M·卡恰林 A·卡尔松 M·图尔基亚 于 2020-04-28 设计创作，主要内容包括：本发明涉及鉴定患者数据内指示NTRK致癌融合的一个或多个候选标志。本发明的主题是用于从与受试患者相关的患者数据确定概率值的计算机实施的方法、系统和非暂时性计算机可读存储介质,所述概率值指示受试患者患有由神经营养受体酪氨酸激酶(NTRK)基因突变所引起的癌症的概率。(The present invention relates to identifying one or more candidate markers within patient data indicative of NTRK oncogenic fusion. The subject of the present invention are computer-implemented methods, systems, and non-transitory computer-readable storage media for determining a probability value from patient data associated with a subject patient, the probability value indicating a probability that the subject patient has a cancer caused by a mutation in a neurotrophic receptor tyrosine kinase (NTRK) gene.)